. "[3AF400B91AFA]" . . "15" . . "\u0160pinar, Jind\u0159ich" . "I" . "guidelines; heart failure; differences"@en . . "V roce 2012 vy\u0161la \u010Desk\u00E1 i evropsk\u00E1 doporu\u010Dn\u00ED pro diagnostiku a l\u00E9\u010Dbu srde\u010Dn\u00EDho selh\u00E1ni. Auto\u0159i \u010Desk\u00FDch doporu\u010Den\u00ED srovn\u00E1vaj\u00ED oba dokumenty. Hlavn\u00ED rozd\u00EDl je v tom, \u017Ee evropsk\u00E1 doporu\u010Den\u00ED zahrnuj\u00ED i akutn\u00ED srde\u010Dn\u00ED selh\u00E1n\u00ED, zat\u00EDmco na\u0161e n\u00E1rodn\u00ED pouze chronick\u00E9 srde\u010Dn\u00ED selh\u00E1n\u00ED. Rozd\u00EDl je ji\u017E v definici srde\u010Dn\u00EDho selh\u00E1n\u00ED: evropsk\u00E1 doporu\u010Den\u00ED nemaj\u00ED v diagnostick\u00FDch kriteri\u00EDch zahrnuty natriuretick\u00E9 peptidy a v p\u0159\u00EDpad\u011B sporn\u00E9 diagnozy nen\u00ED jako pomocn\u00E9 krit\u00E9rium odpov\u011B\u010F na l\u00E9\u010Dbu. \u010C\u00E1ste\u010Dn\u011B se li\u0161\u00ED d\u011Blen\u00ED zn\u00E1mek a symptomu srde\u010Dn\u00EDho selh\u00E1ni v obou doporu\u010Den\u00EDch. V diagnostice srde\u010Dn\u00EDho selh\u00E1n\u00ED jsou m\u00EDrn\u00E9 rozd\u00EDly v norm\u00E1ch pro echokardiografick\u00E9 parametry, p\u0159edev\u0161\u00EDm pro parametry diastolick\u00E9 dysfunkce. Pozm\u011Bn\u011Bny jsou normy pro natriuretick\u00E9 peptidy a to pro neakutn\u011B p\u0159ich\u00E1zej\u00EDc\u00ED pacienty, u nich\u017E je hrani\u010Dn\u00ED hodnota NT-proBNP pod 125 pg/ml a 35 pg/ml pro BNP. V l\u00E9\u010Db\u011B srde\u010Dn\u00EDho selh\u00E1n\u00ED jsou stejn\u00E9 l\u00E9kov\u00E9 skupiny. U ACE inhibitoru nen\u00ED v evropsk\u00FDch doporu\u010Den\u00EDch uveden perindopril a ramipril m\u00E1 c\u00EDlovou d\u00E1vku dvakr\u00E1t 5 mg, zat\u00EDmco v \u010Desk\u00FDch jedenkr\u00E1t 10mg. Losartan m\u00E1 v \u010Desk\u00FDch doporu\u010Den\u00EDch c\u00EDlovou d\u00E1vku 100mg, v evropsk\u00FDch doporu\u010Den\u00EDch 150mg jedenkr\u00E1t denn\u011B. Mezi doporu\u010Den\u00FDmi diuretiky je v evropsk\u00FDch doporu\u010Den\u00EDch triamteren a amilorid, kter\u00E9 nejsou uvedeny v \u010Desk\u00FDch."@cs . "Li\u0161\u00ED se ESC a \u010CKS doporu\u010Den\u00ED pro diagnostiku a l\u00E9\u010Dbu srde\u010Dn\u00EDho selh\u00E1n\u00ED?" . "V roce 2012 vy\u0161la \u010Desk\u00E1 i evropsk\u00E1 doporu\u010Dn\u00ED pro diagnostiku a l\u00E9\u010Dbu srde\u010Dn\u00EDho selh\u00E1ni. Auto\u0159i \u010Desk\u00FDch doporu\u010Den\u00ED srovn\u00E1vaj\u00ED oba dokumenty. Hlavn\u00ED rozd\u00EDl je v tom, \u017Ee evropsk\u00E1 doporu\u010Den\u00ED zahrnuj\u00ED i akutn\u00ED srde\u010Dn\u00ED selh\u00E1n\u00ED, zat\u00EDmco na\u0161e n\u00E1rodn\u00ED pouze chronick\u00E9 srde\u010Dn\u00ED selh\u00E1n\u00ED. Rozd\u00EDl je ji\u017E v definici srde\u010Dn\u00EDho selh\u00E1n\u00ED: evropsk\u00E1 doporu\u010Den\u00ED nemaj\u00ED v diagnostick\u00FDch kriteri\u00EDch zahrnuty natriuretick\u00E9 peptidy a v p\u0159\u00EDpad\u011B sporn\u00E9 diagnozy nen\u00ED jako pomocn\u00E9 krit\u00E9rium odpov\u011B\u010F na l\u00E9\u010Dbu. \u010C\u00E1ste\u010Dn\u011B se li\u0161\u00ED d\u011Blen\u00ED zn\u00E1mek a symptomu srde\u010Dn\u00EDho selh\u00E1ni v obou doporu\u010Den\u00EDch. V diagnostice srde\u010Dn\u00EDho selh\u00E1n\u00ED jsou m\u00EDrn\u00E9 rozd\u00EDly v norm\u00E1ch pro echokardiografick\u00E9 parametry, p\u0159edev\u0161\u00EDm pro parametry diastolick\u00E9 dysfunkce. Pozm\u011Bn\u011Bny jsou normy pro natriuretick\u00E9 peptidy a to pro neakutn\u011B p\u0159ich\u00E1zej\u00EDc\u00ED pacienty, u nich\u017E je hrani\u010Dn\u00ED hodnota NT-proBNP pod 125 pg/ml a 35 pg/ml pro BNP. V l\u00E9\u010Db\u011B srde\u010Dn\u00EDho selh\u00E1n\u00ED jsou stejn\u00E9 l\u00E9kov\u00E9 skupiny. U ACE inhibitoru nen\u00ED v evropsk\u00FDch doporu\u010Den\u00EDch uveden perindopril a ramipril m\u00E1 c\u00EDlovou d\u00E1vku dvakr\u00E1t 5 mg, zat\u00EDmco v \u010Desk\u00FDch jedenkr\u00E1t 10mg. Losartan m\u00E1 v \u010Desk\u00FDch doporu\u010Den\u00EDch c\u00EDlovou d\u00E1vku 100mg, v evropsk\u00FDch doporu\u010Den\u00EDch 150mg jedenkr\u00E1t denn\u011B. Mezi doporu\u010Den\u00FDmi diuretiky je v evropsk\u00FDch doporu\u010Den\u00EDch triamteren a amilorid, kter\u00E9 nejsou uvedeny v \u010Desk\u00FDch." . "2" . "Are the ESC and CKS guidelines for diagnostics and treatment of heart failure different?"@en . . . "RIV/65269705:_____/13:#0002151" . . . . . "In 2012, Czech and European guidelines for the diagnosis and treatment of heart failure were published. The authors of the Czech guidelines compared both documents. The main difference is that the European guidelines include acute heart failure, while our national guidelines include only chronic heart failure. The difference is already in the definition of heart failure: the European guidelines do not include natriuretic peptides in the diagnostic criteria and in case of controversial diagnosis, treatment response is not an additional criterion. There is also a partial difference in division of signs and symptoms of heart failure in both recommendations. In the diagnosis of heart failure, there are slight differences in the standards for echo-cardiographic parameters, especially the parameters of diastolic dysfunction. Standards for natriuretic pep-tides were changed for non-emergency incoming patients for whom the marginal value of NT-proBNP is below 125 pg/ml and 35 pg/ml for BNP. In the treatment of heart failure, there are the same drug groups. In the European guidelines, for ACE inhibitors, ramipril is not included and perindopril has a target dose of twice 5 mg, while in the Czech guidelines, it is once 10 mg. In the Czech guidelines, Losartan hasatarget dose of 100 mg, while in the European guidelines it is 150 mg once daily. Among diuretics, in European guidelines, there are triamterene and amiloride, which are not included in Czech guidelines.."@en . "5"^^ . "1212-4540" . "Li\u0161\u00ED se ESC a \u010CKS doporu\u010Den\u00ED pro diagnostiku a l\u00E9\u010Dbu srde\u010Dn\u00EDho selh\u00E1n\u00ED?"@cs . "Li\u0161\u00ED se ESC a \u010CKS doporu\u010Den\u00ED pro diagnostiku a l\u00E9\u010Dbu srde\u010Dn\u00EDho selh\u00E1n\u00ED?"@cs . . "RIV/65269705:_____/13:#0002151!RIV14-MZ0-65269705" . . "CZ - \u010Cesk\u00E1 republika" . . "85082" . . . "2"^^ . "Li\u0161\u00ED se ESC a \u010CKS doporu\u010Den\u00ED pro diagnostiku a l\u00E9\u010Dbu srde\u010Dn\u00EDho selh\u00E1n\u00ED?" . "Are the ESC and CKS guidelines for diagnostics and treatment of heart failure different?"@en . "1"^^ . "Kardiologick\u00E1 revue" .